H.R.4991: Affordable Pricing for Taxpayer-Funded Prescription Drugs Act of 2021

About This Bill

Bill Version

Bill Summary

Affordable Pricing for Taxpayer-Funded Prescription Drugs Act of 2021 This bill requires companies that receive federal funding for research (or a license of the rights to a patent or regulatory test data) for a biomedical product or service to agree to set reasonable prices for the resulting biomedical product or service. The Department of Health and Human Services (HHS) must determine a reasonable price based on a formula that ensures the...

(Source: Library of Congress)

Bill Actions

Date Description
Aug. 11, 2021
Referred to the Subcommittee on Health.
Aug. 10, 2021
Referred to the House Committee on Energy and Commerce.
Aug. 10, 2021

Introduced in the House by Peter A. DeFazio (D-Ore.)

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page